Latest news

IMATHERa (CGFL) was present at the World Molecular Imaging Congress (WMIC) in Prague. Dr Alexandre Dias (CGFL) and Dr Bertrand Collin (CGFL / ICMUB – UMR CNRS 6302) presented their research work part of the EQUIPEX IMAPPI (ANR-10-EQPX-0005) program on:

– Preclinical theranostic PET imaging in CD30-positive cancers with [Zr89]Zr-DFO-Brentuximab vedotin.

– SPIOs development for theranostic purposes in glioblastoma.

On this occasion, the title of Scientific Ambassador for France was awarded to Dr Alexandre Dias for his work on the use of SPIOs in the treatment of glioblastoma, in collaboration with the Dijon-based company SON SAS.

A new review article, co-authored by Drs Jame Frenay and Pierre-Simon Bellaye (Supervisor: Dr Alexandre Dias), has just been published by IMATHERa (CGFL – Dr B. Collin, ICMUB UMR CNRS 6302). This literature review highlights the fact that IL-1RAP, a receptor involved in the inflammatory response, is now considered as a promising therapeutic target in several hematological and solid cancers: see publication.

A new review article, co-authored by Drs Alexandre Dias and Alan Courteau, has just been published by IMATHERa (CGFL – Dr B. Collin, ICMUB UMR CNRS 6302).

This literature review highlights the theranostic potential of innovative superparamagnetic nanoparticles for cancer immunotherapy via magnetic hyperthermia and targeting of M2 macrophages: https://www.mdpi.com/1999-4923/14/11/2388.